PATENT CLAIM ANALYSIS

Application Number: 16115018
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["514", "683000"]

Abstract:
The present invention relates to use of a composition comprising a panduratin derivative or a  boesenbergia pandurata  extract as an effective ingredient, which suppresses the differentiation of osteoclasts to exhibit the effect of treating, preventing or ameliorating bone loss diseases and which can be used safely as a natural material without side effects, thus finding effective applications in drugs, quasi-drugs, or foods.

Claim (Index 3):
The method of  claim 2 , wherein the C1-C6 organic solvent is at least one selected from the group consisting of a C1-C6 alcohol, acetone, ether, benzene, chloroform, ethyl acetate, methylene chloride, hexane, cyclohexane, and petroleum ether.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 96.0
- Lexical Diversity: 1.30769
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13123519', '11705689', '13384560', '13457967', '14293879']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7572098018303106
- 35 USC 102 Novelty (BERT): 0.5201994126477449
- Combined Prediction Score: 0.733508762912054
- Mean Citation Score: 210.13944
- Max Citation Score: 224.8726
- Similarity Product: 121.73641881804468

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test